BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer. 2009;9:155. [PMID: 19457231 DOI: 10.1186/1471-2407-9-155] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Bacanakgil BH, Kaban I, Unal F, Guven R, Sahin E, Yildirim SG. Predictive Value of Hematological Inflammatory Markers in Endometrial Neoplasia. Asian Pac J Cancer Prev 2018;19:1529-32. [PMID: 29936727 DOI: 10.22034/APJCP.2018.19.6.1529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Matowicka-Karna J, Kamocki Z, Polińska B, Osada J, Kemona H. Platelets and inflammatory markers in patients with gastric cancer. Clin Dev Immunol 2013;2013:401623. [PMID: 23554823 DOI: 10.1155/2013/401623] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
3 Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediators Inflamm 2019;2019:9213074. [PMID: 31148950 DOI: 10.1155/2019/9213074] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 25.0] [Reference Citation Analysis]
4 Crumley AB, Stuart RC, McKernan M, McMillan DC. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010;34:2393-2398. [PMID: 20602101 DOI: 10.1007/s00268-010-0641-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
5 Abe A, Kuwata T, Yamauchi C, Higuchi Y, Ochiai A. High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts. Pathol Int 2014;64:267-75. [PMID: 24965109 DOI: 10.1111/pin.12167] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
6 Lee CH, Lin C, Wang CY, Huang TC, Wu YY, Chien WC, Chen JH. Premorbid BMI as a prognostic factor in small-cell lung cancer-a single institute experience. Oncotarget 2018;9:24642-52. [PMID: 29872494 DOI: 10.18632/oncotarget.24935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Madej-Michniewicz A, Budkowska M, Sałata D, Dołęgowska B, Starzyńska T, Błogowski W. Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary report. Sci Rep 2015;5:14382. [PMID: 26486258 DOI: 10.1038/srep14382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Xia WK, Lin QF, Shen D, Liu ZL, Su J, Mao WD. Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis. FEBS Open Bio 2016;6:558-65. [PMID: 27419058 DOI: 10.1002/2211-5463.12066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
9 Chapelle N, Osmola M, Martin J, Blin J, Leroy M, Jirka I, Moussata D, Lamarque D, Olivier R, Tougeron D, Hay-lombardie A, Bigot-corbel E, Masson D, Mosnier J, Matysiak-budnik T. Serum Pepsinogens Combined with New Biomarkers Testing Using Chemiluminescent Enzyme Immunoassay for Non-Invasive Diagnosis of Atrophic Gastritis: A Prospective, Multicenter Study. Diagnostics 2022;12:695. [DOI: 10.3390/diagnostics12030695] [Reference Citation Analysis]
10 Yamamoto M, Kurokawa Y, Miyazaki Y, Makino T, Takahashi T, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence. World J Surg. 2016;40:1904-1909. [PMID: 26969673 DOI: 10.1007/s00268-016-3474-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
11 Dias Rodrigues V, Barroso de Pinho N, Abdelhay E, Viola JP, Correia MI, Brum Martucci R. Nutrition and Immune-Modulatory Intervention in Surgical Patients With Gastric Cancer. Nutr Clin Pract. 2017;32:122-129. [PMID: 27329862 DOI: 10.1177/0884533616653807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
12 da Costa Jde F, Leal MF, Silva TC, Andrade Junior EF, Rezende AP, Muniz JA, Lacreta Junior AC, Assumpção PP, Calcagno DQ, Demachki S, Rabenhorst SH, Smith Mde A, Burbano RR. Experimental gastric carcinogenesis in Cebus apella nonhuman primates. PLoS One 2011;6:e21988. [PMID: 21811552 DOI: 10.1371/journal.pone.0021988] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
13 Casadei Gardini A, Carloni S, Scarpi E, Maltoni P, Dorizzi RM, Passardi A, Frassineti GL, Cortesi P, Giannini MB, Marisi G, Amadori D, Lucchesi A. Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial. Oncotarget 2016;7:10193-202. [PMID: 26848624 DOI: 10.18632/oncotarget.7166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
14 Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma. Tumour Biol 2015;36:7515-20. [PMID: 25913621 DOI: 10.1007/s13277-015-3464-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
15 Angin YS, Yildirim M, Dasiran F, Okan I. Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer? ANZ J Surg 2021;91:1521-7. [PMID: 33956378 DOI: 10.1111/ans.16913] [Reference Citation Analysis]
16 Asanuma K, Nakamura T, Asanuma Y, Kakimoto T, Yada Y, Hagi T, Kita K, Matsumine A, Sudo A. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas. Cancer Biomark 2019;26:163-70. [PMID: 31356193 DOI: 10.3233/CBM-182075] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Kim SH, Park EY, Joo J, Chung J. The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma. J Oncol 2018;2018:1953571. [PMID: 30662462 DOI: 10.1155/2018/1953571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
18 Aldaham S, Foote JA, Chow HH, Hakim IA. Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers. Int J Inflam 2015;2015:439396. [PMID: 26366318 DOI: 10.1155/2015/439396] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
19 Cheng S, Han F, Wang Y, Xu Y, Qu T, Ju Y, Lu Z. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. BMC Gastroenterol 2017;17:163. [PMID: 29262773 DOI: 10.1186/s12876-017-0685-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
20 Li R, Hou J, Xu Q, Liu Q, Shen Y, Rodin G, Li M. High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line. Metab Brain Dis 2012;27:91-100. [DOI: 10.1007/s11011-011-9270-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
21 Zou ZY, Liu HL, Ning N, Li SY, DU XH, Li R. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett. 2016;11:2241-2248. [PMID: 26998156 DOI: 10.3892/ol.2016.4216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 7.5] [Reference Citation Analysis]
22 Shao N, Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 2015;17:772-8. [PMID: 26243392 DOI: 10.1007/s12094-015-1289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
23 Wang H, Ding Y, Li N, Wu L, Gao Y, Xiao C, Jiang H, Zheng Y, Mao C, Deng J, Wang H, Xu N. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Front Oncol 2020;10:841. [PMID: 32637353 DOI: 10.3389/fonc.2020.00841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Nedić O, Miljuš G, Malenković V. Regulation of Insulin and Insulin-Like Activity in Malnourished Patients with Carcinoma Ventriculi Subjected to Total Gastrectomy and Personalized Nutritional Support. J Med Biochem 2016;35:17-25. [PMID: 28356860 DOI: 10.1515/jomb-2015-0013] [Reference Citation Analysis]
25 Kemal Y, Demirağ G, Ekiz K, Yücel I. Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer. J Obstet Gynaecol 2014;34:515-8. [PMID: 24832894 DOI: 10.3109/01443615.2014.912620] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
26 Engin AB, Engin A, Sepici-dincel A. Influence of Surgical Trauma on Neopterin Concentrations in Gastric Carcinoma Patients. Tumori 2010;96:589-93. [DOI: 10.1177/030089161009600412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang S, Chen M, Shen Y, Shen W, Guo H, Gao Q, Zou X. Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer Letters 2012;315:198-205. [DOI: 10.1016/j.canlet.2011.10.011] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 6.9] [Reference Citation Analysis]
28 Kim SH, Kwon W, Kim S, Joung JY, Seo HK, Lee KH, Chung J. The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients. Japanese Journal of Clinical Oncology 2018;48:835-40. [DOI: 10.1093/jjco/hyy098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Zhu GS, Tian SB, Wang H, Ma MG, Liu Y, Du HS, Long YP. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Curr Med Sci. 2018;38:78-84. [PMID: 30074155 DOI: 10.1007/s11596-018-1849-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
30 Kılınçalp S, Ekiz F, Başar O, Ayte MR, Coban S, Yılmaz B, Altınbaş A, Başar N, Aktaş B, Tuna Y, Erbiş H, Uçar E, Erarslan E, Yüksel O. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets 2014;25:592-4. [PMID: 23537073 DOI: 10.3109/09537104.2013.783689] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
31 Ibrahim AS, Farrag WS, Galal Aly M. Ultrasound guided bilateral rectus sheath block and serum TNF-α and IL-6 after radical prostatectomy: A randomized double blinded study. Egyptian Journal of Anaesthesia 2019;34:139-43. [DOI: 10.1016/j.egja.2018.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Csendes JA, Muñoz ChA, Burgos L. Blood count and C-reactive protein evolution in gastric cancer patients with total gastrectomy surgery. Arq Bras Cir Dig 2014;27:234-6. [PMID: 25626929 DOI: 10.1590/S0102-67202014000400002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, Kim MC, Kim KH, Kim SJ, Kim SG, Kim HJ. Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients. World J Gastroenterol 2012; 18(34): 4744-4750 [PMID: 23002344 DOI: 10.3748/wjg.v18.i34.4744] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
34 Aurello P, Tierno SM, Berardi G, Tomassini F, Magistri P, D'Angelo F, Ramacciato G. Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer. Ann Surg Oncol 2014;21:1998-2004. [PMID: 24515568 DOI: 10.1245/s10434-014-3533-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
35 Kim J, Pyun JA, Cho SW, Lee K, Kwack K. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. DNA Cell Biol. 2011;30:1011-1017. [PMID: 21612407 DOI: 10.1089/dna.2011.1250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
36 Geng Y, Mei Y, Xi Y, Yu J, Meng K, Zhang T, Ma W. Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations. Onco Targets Ther 2020;13:11089-95. [PMID: 33149620 DOI: 10.2147/OTT.S266477] [Reference Citation Analysis]
37 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med 2013;6:1369-74. [PMID: 24255664 DOI: 10.3892/etm.2013.1350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
38 Kang MH, Go SI, Song HN, Lee A, Kim SH, Kang JH, Jeong BK, Kang KM, Ling H, Lee GW. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer 2014;111:452-60. [PMID: 24921916 DOI: 10.1038/bjc.2014.317] [Cited by in Crossref: 101] [Cited by in F6Publishing: 119] [Article Influence: 12.6] [Reference Citation Analysis]
39 Jiang Y, Xu H, Jiang H, Ding S, Zheng T. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence. Cancer Biomark 2016;16:523-8. [PMID: 27062567 DOI: 10.3233/CBM-160593] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
40 Sonawane MD, Nimse SB. C-Reactive protein: a major inflammatory biomarker. Anal Methods 2017;9:3400-13. [DOI: 10.1039/c7ay00711f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
41 Yin Y, Si X, Gao Y, Gao L, Wang J. The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol Rep. 2013;29:34-38. [PMID: 23117246 DOI: 10.3892/or.2012.2089] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
42 Szczepanik AM, Scislo L, Scully T, Walewska E, Siedlar M, Kolodziejczyk P, Lenart M, Rutkowska M, Galas A, Czupryna A. IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer. 2011;14:266-273. [PMID: 21505767 DOI: 10.1007/s10120-011-0039-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
43 Jin Z, Jiang W, Wang L. Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review). Oncol Lett. 2015;9:1502-1508. [PMID: 25788990 DOI: 10.3892/ol.2015.2959] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
44 Kemal Y, Demirag G, Baş B, Önem S, Teker F, Yücel İ. The value of red blood cell distribution width in endometrial cancer. Clin Chem Lab Med 2015;53:823-7. [PMID: 25860865 DOI: 10.1515/cclm-2014-0699] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
45 Jeon HJ, Kim JM, Cho CK, Lee YW, Yoo HS. Wheel Balanced Cancer Therapy for Longer Than 21 Days Can Have a Positive Effect on the Survival of Patients with Stage IV Cancer. J Pharmacopuncture 2015;18:19-31. [PMID: 26388999 DOI: 10.3831/KPI.2015.18.021] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Kim WR, Han YD, Min BS. C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy. Ann Surg Oncol 2018;25:3898-905. [PMID: 30288654 DOI: 10.1245/s10434-018-6828-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
47 Preisner F, Leimer U, Sandmann S, Zoernig I, Germann G, Koellensperger E. Impact of Human Adipose Tissue-Derived Stem Cells on Malignant Melanoma Cells in An In Vitro Co-culture Model. Stem Cell Rev Rep 2018;14:125-40. [PMID: 29064018 DOI: 10.1007/s12015-017-9772-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
48 Nakamura N, Kinami S, Fujii Y, Miura S, Fujita J, Kaida D, Tomita Y, Miyata T, Fujita H, Ueda N, Iida Y, Kosaka T. The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis. World J Surg Oncol 2019;17:108. [PMID: 31238937 DOI: 10.1186/s12957-019-1651-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
49 A. Richard S; Department of Medicine, Princefield University, P. O. Box MA 128, Ho-Volta Region, Ghana West Africa. . AIMS Molecular Science 2018;5:183-241. [DOI: 10.3934/molsci.2018.4.183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Tüzün A, Keskin O, Yakut M, Kalkan C, Soykan I. The predictive value of mean platelet volume, plateletcrit and red cell distribution width in the differentiation of autoimmune gastritis patients with and without type I gastric carcinoid tumors. Platelets 2014;25:363-6. [PMID: 24175991 DOI: 10.3109/09537104.2013.821607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Matsubara D, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Kudou M, Konishi H, Komatsu S, Shiozaki A, Otsuji E. The impact of postoperative inflammation on recurrence in patients with colorectal cancer. Int J Clin Oncol 2020;25:602-13. [PMID: 31758273 DOI: 10.1007/s10147-019-01580-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
52 Gür EÖ, Karaisli S, Kamer E, Kar H, Emecen AN, Ekinci N, Dilek ON, Hacıyanlı M. Predictive Factors for Lymph Node Metastasis and the Effect on Survival in Early Gastric Cancer Patients with Radical Gastric Resection. Sisli Etfal Hastan Tip Bul 2019;53:371-8. [PMID: 32377111 DOI: 10.14744/SEMB.2019.30643] [Reference Citation Analysis]
53 Zhang J, Wang P, Ouyang H, Yin J, Liu A, Ma C, Liu L. Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer. PLoS One 2013;8:e70334. [PMID: 23922983 DOI: 10.1371/journal.pone.0070334] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
54 Łukaszewicz-zając M, Szmitkowski M, Litman-zawadzka A, Mroczko B. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC). Cancer Investigation 2016;34:305-12. [DOI: 10.1080/07357907.2016.1197237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
55 Yang L, Yu X, Yang Y. Autotaxin upregulated by STAT3 activation contributes to invasion in pancreatic neuroendocrine neoplasms. Endocr Connect 2018;7:1299-307. [PMID: 30352421 DOI: 10.1530/EC-18-0356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
56 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
57 Sun HL, Pan YQ, He BS, Nie ZL, Lin K, Peng HX, Cho WC, Wang SK. Prognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports. Onco Targets Ther 2016;9:3017-23. [PMID: 27284252 DOI: 10.2147/OTT.S96910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
58 Kang HW, Seo SP, Kim WT, Yun SJ, Lee S, Kim W, Hwang EC, Kang SH, Hong S, Chung J, Kwon TG, Hoe Kim H, Kwak C, Byun S, Kim Y; The KORCC (KOrean Renal Cell Carcinoma) group. Prognostic Impact of Nutritional Status Assessed by the Controlling Nutritional Status (CONUT) Score in Patients with Surgically Treated Renal Cell Carcinoma. Nutrition and Cancer 2018;70:886-94. [DOI: 10.1080/01635581.2018.1490448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
59 Shrotriya S, Walsh D, Bennani-Baiti N, Thomas S, Lorton C. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One 2015;10:e0143080. [PMID: 26717416 DOI: 10.1371/journal.pone.0143080] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 16.1] [Reference Citation Analysis]
60 Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, Sano T, Yamaguchi T. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275-279. [PMID: 22713657 DOI: 10.1038/bjc.2012.262] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
61 Wakahara T, Ueno N, Maeda T, Kanemitsu K, Yoshikawa T, Tsuchida S, Toyokawa A. Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers? Gastroenterology Res 2017;10:359-65. [PMID: 29317944 DOI: 10.14740/gr943w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Nakamura T, Grimer R, Gaston C, Francis M, Charman J, Graunt P, Uchida A, Sudo A, Jeys L. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma. Eur J Cancer 2013;49:377-85. [PMID: 23058786 DOI: 10.1016/j.ejca.2012.09.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
63 Yang Y, Yang L, Li Y. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms. Hum Pathol. 2018;81:192-200. [PMID: 30420046 DOI: 10.1016/j.humpath.2018.06.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
64 Zhu BH, Chen HY, Zhan WH, Wang CY, Cai SR, Wang Z, Zhang CH, He YL. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol 2011; 17(18): 2315-2325 [PMID: 21633597 DOI: 10.3748/wjg.v17.i18.2315] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
65 Łukaszewicz-zając M, Mroczko B, Kozłowski M, Nikliński J, Laudański J, Szmitkowski M. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients: IL-6 in EC, ESCC, and AD patients. Diseases of the Esophagus 2012;25:242-9. [DOI: 10.1111/j.1442-2050.2011.01242.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
66 Aguiar SS, Sousa CV, Deus LA, Rosa TS, Sales MM, Neves RVP, Barbosa LP, Santos PA, Campbell CS, Simões HG. Oxidative stress, inflammatory cytokines and body composition of master athletes: The interplay. Experimental Gerontology 2020;130:110806. [DOI: 10.1016/j.exger.2019.110806] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
67 Bocharova OA, Bocharov EV, Karpova RV, Il’enko VA, Kazeev IV, Baryshnikov AY. Integrins LFA-1 and Mac-1 and Cytokines IL-6 and IL-10 in High-Cancer Mice under the Influence of Phytoadaptogen. Bull Exp Biol Med 2014;157:258-60. [DOI: 10.1007/s10517-014-2539-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
68 Formica V, Morelli C, Patrikidou A, Murias C, Butt S, Nardecchia A, Lucchetti J, Renzi N, Shiu K, Roselli M, Arkenau H. Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors. Targ Oncol 2020;15:327-36. [DOI: 10.1007/s11523-020-00723-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
69 Wang X, Li J, Liu W, Zhang X, Xue L. The diagnostic value of interleukin 6 as a biomarker for gastric cancer: A meta-analysis and systematic review. Medicine 2021;100:e27945. [DOI: 10.1097/md.0000000000027945] [Reference Citation Analysis]
70 Lukaszewicz-Zając M, Mroczko B, Gryko M, Kędra B, Szmitkowski M. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med. 2011;11:89-96. [PMID: 20938721 DOI: 10.1007/s10238-010-0114-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
71 Chen X, Li J, Zhang X, Liu Y, Wu J, Li Y, Cui X, Jiang X. Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis. BMJ Open 2020;10:e037614. [PMID: 33109647 DOI: 10.1136/bmjopen-2020-037614] [Reference Citation Analysis]
72 Ruzzo A, Catalano V, Canestrari E, Giacomini E, Santini D, Tonini G, Vincenzi B, Fiorentini G, Magnani M, Graziano F. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy. BMC Cancer 2014;14:357. [PMID: 24886605 DOI: 10.1186/1471-2407-14-357] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
73 Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T. Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol. 2011;103:801-806. [PMID: 21240991 DOI: 10.1002/jso.21857] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
74 Yang S, He X, Liu Y, Ding X, Jiang H, Tan Y, Lu H. Prognostic Significance of Serum Uric Acid and Gamma-Glutamyltransferase in Patients with Advanced Gastric Cancer. Dis Markers 2019;2019:1415421. [PMID: 31885729 DOI: 10.1155/2019/1415421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
75 Xia Y, Khoi PN, Yoon HJ, Lian S, Joo YE, Chay KO, Kim KK, Jung YD. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells. Mol Cell Biochem 2015;398:147-56. [DOI: 10.1007/s11010-014-2214-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
76 Baranyai Z, Jósa V, Tóth A, Szilasi Z, Tihanyi B, Zaránd A, Harsanyi L, Szállási Z. Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets 2016;27:269-75. [PMID: 27136385 DOI: 10.3109/09537104.2016.1170112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
77 Pozas J, San Román M, Alonso-Gordoa T, Pozas M, Caracuel L, Carrato A, Molina-Cerrillo J. Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms. Int J Mol Sci 2019;20:E4949. [PMID: 31597249 DOI: 10.3390/ijms20194949] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
78 Metgud R, Bajaj S. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma. Biotech Histochem 2016;91:96-101. [PMID: 26529498 DOI: 10.3109/10520295.2015.1077393] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
79 Song YJ, Wang LX, Hong YQ, Lu ZH, Tong Q, Fang XZ, Tan J. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients. Tumour Biol 2016;37:5285-93. [PMID: 26561466 DOI: 10.1007/s13277-015-4397-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
80 Coutant DE, Kulanthaivel P, Turner PK, Bell RL, Baldwin J, Wijayawardana SR, Pitou C, Hall SD. Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window. Clin Pharmacol Ther 2015;98:76-86. [PMID: 25808023 DOI: 10.1002/cpt.128] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
81 Kanz R, Vukovich T, Vormittag R, Dunkler D, Ay C, Thaler J, Haselböck J, Scheithauer W, Zielinski C, Pabinger I. Thrombosis risk and survival in cancer patients with elevated C-reactive protein. J Thromb Haemost 2011;9:57-63. [PMID: 20874781 DOI: 10.1111/j.1538-7836.2010.04069.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
82 Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. [PMID: 23876227 DOI: 10.1186/1471-2407-13-350] [Cited by in Crossref: 158] [Cited by in F6Publishing: 178] [Article Influence: 17.6] [Reference Citation Analysis]
83 Lee S, Choe JW, Kim HK, Sung J. High-sensitivity C-reactive protein and cancer. J Epidemiol. 2011;21:161-168. [PMID: 21368452 DOI: 10.2188/jea.je20100128] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
84 Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg 2018;56:320-7. [PMID: 29969732 DOI: 10.1016/j.ijsu.2018.06.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
85 Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, Steer S, Merriman TR, Vyse TJ. A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 2010;7:e1000341. [PMID: 20877716 DOI: 10.1371/journal.pmed.1000341] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
86 Ock CY, Nam AR, Lee J, Bang JH, Lee KH, Han SW, Kim TY, Im SA, Kim TY, Bang YJ, Oh DY. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Gastric Cancer. 2017;20:254-262. [PMID: 27147244 DOI: 10.1007/s10120-016-0613-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
87 Groblewska M, Mroczko B, Sosnowska D, Szmitkowski M. Interleukin 6 and C-reactive protein in esophageal cancer. Clinica Chimica Acta 2012;413:1583-90. [DOI: 10.1016/j.cca.2012.05.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
88 Chen Z, Sun Y, Wang J, Shen X, Chen L, Zhuang Z. Prognostic and Predictive Value of Serum C-Reactive Protein Levels in Patients with Metastatic Or Locally Recurrent Gastric Cancer. Int J Biol Markers 2016;31:294-9. [DOI: 10.5301/jbm.5000210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
89 Yang CL, Liu YY, Ma YG, Xue YX, Liu DG, Ren Y, Liu XB, Li Y, Li Z. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 2012;7:e37960. [PMID: 22662257 DOI: 10.1371/journal.pone.0037960] [Cited by in Crossref: 134] [Cited by in F6Publishing: 127] [Article Influence: 13.4] [Reference Citation Analysis]
90 Masoumi H, Soltani A, Ghatrehsamani M. The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6. Mol Biol Rep 2020;47:129-39. [PMID: 31781916 DOI: 10.1007/s11033-019-05114-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
91 Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR. Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10:3411-3418. [PMID: 26788143 DOI: 10.3892/ol.2015.3783] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
92 K V M, Jonnada P, N SK, Anwar A. Role of Mean Platelet Volume in the Prognosis of Locally Advanced Gastric Cancer: A Tertiary Cancer Center Experience. Cureus 2020;12:e9109. [PMID: 32789054 DOI: 10.7759/cureus.9109] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer 2012;118:1055-61. [PMID: 21761398 DOI: 10.1002/cncr.26353] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
94 Woo Y, Hyung WJ, Obama K, Kim HI, Pak KH, Son T, Noh SH. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. J Surg Oncol. 2012;105:405-409. [PMID: 22025360 DOI: 10.1002/jso.22129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
95 Gao Y, Wang WJ, Zhi Q, Shen M, Jiang M, Bian X, Gong FR, Zhou C, Lian L, Wu MY, Feng J, Tao M, Li W. Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer. Oncotarget 2017;8:88835-44. [PMID: 29179480 DOI: 10.18632/oncotarget.21340] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
96 Yilmaz E, Gul M, Melekoglu R, Koleli I. Immunhistochemical analysis of Nuclear Factor Kappa Beta expression in etiopathogenesis of ovarian tumors1. Acta Cir Bras 2018;33:641-50. [PMID: 30110065 DOI: 10.1590/s0102-865020180070000009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
97 Monastero RN, Pentyala S. Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels. Int J Inflam 2017;2017:4309485. [PMID: 28487810 DOI: 10.1155/2017/4309485] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 14.4] [Reference Citation Analysis]
98 Wang Q, Song X, Zhao Y, He Q, Shi M, Xu P, Ni S, Chen Y, Lin J, Zhang L. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma. Future Oncol 2019;15:2277-86. [PMID: 31237166 DOI: 10.2217/fon-2019-0063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
99 Kilzi GM, Lavu H. Prognostic value of circulating cytokines in colon cancer recurrence. J Surg Res 2014;186:85-6. [PMID: 23465432 DOI: 10.1016/j.jss.2013.02.004] [Reference Citation Analysis]
100 Ng QX, Soh AYS, Yeo WS. Statistically but not clinically significant? Biomarkers in gastric cancer. Clin Nutr 2018;37:2292-3. [PMID: 30193872 DOI: 10.1016/j.clnu.2018.08.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
101 Kim Y, Kim YM, Kim JH, Youn YH, Kim JW, Park H. Peri-operative Inflammatory Marker as a Predictive Factor for Prolonged Post-operative Ileus After Gastrectomy for Gastric Cancer. J Neurogastroenterol Motil 2021;27:588-95. [PMID: 34642279 DOI: 10.5056/jnm20203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Middleton K, Jones J, Lwin Z, Coward JI. Interleukin-6: an angiogenic target in solid tumours. Crit Rev Oncol Hematol. 2014;89:129-139. [PMID: 24029605 DOI: 10.1016/j.critrevonc.2013.08.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
103 Koper-Lenkiewicz OM, Dymicka-Piekarska V, Milewska AJ, Zińczuk J, Kamińska J. The Relationship between Inflammation Markers (CRP, IL-6, sCD40L) and Colorectal Cancer Stage, Grade, Size and Location. Diagnostics (Basel) 2021;11:1382. [PMID: 34441316 DOI: 10.3390/diagnostics11081382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Mondal SK, Sen MK. Loss of phosphatase activity in PTEN (phosphatase and tensin homolog deleted on chromosome ten) results in endometrial carcinoma in humans: An in-silico study. Heliyon 2020;6:e03106. [PMID: 32042934 DOI: 10.1016/j.heliyon.2019.e03106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Pak K, Kim S, Kim IJ, Kim DU, Kim K, Kim H. Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. Nuclear Medicine Communications 2013;34:64-70. [DOI: 10.1097/mnm.0b013e3283595cac] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
106 Vainer N, Dehlendorff C, Johansen JS. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget. 2018;9:29820-29841. [PMID: 30038723 DOI: 10.18632/oncotarget.25661] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
107 Nesseler JP, Schaue D, McBride WH, Nickers P. [Inflammatory and immune biomarkers of radiation response]. Cancer Radiother 2018;22:180-92. [PMID: 29650389 DOI: 10.1016/j.canrad.2017.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Chen MF, Chen PT, Lu MS, Lin PY, Chen WC, Lee KD. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Mol Cancer 2013;12:26. [PMID: 23561329 DOI: 10.1186/1476-4598-12-26] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
109 Lin M, Huang J, Zhu J, Shen H. Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med. 2013;6:1369-1374. [PMID: 24255664 DOI: 10.3892/etm. 2013.1350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Prognostic Significance of Platelet-Based Inflammatory Indicators in Patients with Gastric Cancer. World J Surg 2018;42:2542-50. [PMID: 29464343 DOI: 10.1007/s00268-018-4527-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
111 Yamashita H, Katai H. Systemic inflammatory response in gastric cancer. World J Surg. 2010;34:2399-2400. [PMID: 20602100 DOI: 10.1007/s00268-010-0703-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
112 Matowicka-Karna J, Kamocki Z, Kemona H. Assessment of platelet activation and phagocytic activity in gastric cancer patients. World J Gastrointest Pathophysiol 2013; 4(1): 12-17 [PMID: 23596550 DOI: 10.4291/wjgp.v4.i1.12] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
113 Lippitz BE, Harris RA. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5:e1093722. [PMID: 27467926 DOI: 10.1080/2162402x.2015.1093722] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 14.5] [Reference Citation Analysis]
114 Li Y, Liu X, Zhang J, Yao W. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma. Cancer Biomark 2016;16:333-42. [PMID: 26835589 DOI: 10.3233/CBM-160571] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
115 Nakamura T, Grimer RJ, Gaston CL, Watanuki M, Sudo A, Jeys L. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone. Bone Joint J 2013;95-B:411-8. [PMID: 23450030 DOI: 10.1302/0301-620X.95B3.30344] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
116 Min KW, Kwon MJ, Kim DH, Son BK, Kim EK, Oh YH, Wi YC. Persistent elevation of postoperative neutrophil-to-lymphocyte ratio: A better predictor of survival in gastric cancer than elevated preoperative neutrophil-to-lymphocyte ratio. Sci Rep 2017;7:13967. [PMID: 29070814 DOI: 10.1038/s41598-017-13969-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
117 Ahn HS, Shin YS, Park PJ, Kang KN, Kim Y, Lee HJ, Yang HK, Kim CW. Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer. 2012;106:733-739. [PMID: 22240791 DOI: 10.1038/bjc.2011.592] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
118 Urbanska AM, Karagiannis ED, Guajardo G, Langer RS, Anderson DG. Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer. Biomaterials 2012;33:4752-61. [PMID: 22472433 DOI: 10.1016/j.biomaterials.2012.03.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
119 Seidensticker M, Powerski M, Seidensticker R, Damm R, Mohnike K, Garlipp B, Klopffleisch M, Amthauer H, Ricke J, Pech M. Cytokines and 90Y-Radioembolization: Relation to Liver Function and Overall Survival. Cardiovasc Intervent Radiol 2017;40:1185-95. [PMID: 28283704 DOI: 10.1007/s00270-017-1622-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
120 Jettoo P, Tan G, Gerrand CH, Rankin KS. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients. J Orthop Surg (Hong Kong) 2019;27:2309499019838293. [PMID: 30909848 DOI: 10.1177/2309499019838293] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]